The global energy based ablation devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of cardiovascular diseases and cancer, rising demand for minimally invasive surgeries, and technological advancements in the field of energy based ablation devices. Electrical energy based ablation devices are expected to dominate the global market during the forecast period due to their high efficacy in treating various types of cancers and other diseases. The segment is also projected to grow at a CAGR of 6% during the forecast period owing to its ability in treating various types of cancers and other diseases with minimal side effects. Light-based energy based ablation devices are projected to witness significant growth over the next few years owing to their ability in treating various types of cancers with minimal side effects. The segment is also projected to grow at a CAGR of 7% during the forecast period due its ability in treating various types of cancers with minimal side effects.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of obesity and diabetes is driving the growth of the energy based ablation devices market.
- The increasing number of people suffering from chronic diseases such as heart disease, cancer, and diabetes is also driving the growth of this market.
- Increasing awareness about energy based ablation devices among physicians and patients is also a major factor that will drive the growth of this market in future years.
- The growing number of hospitals in emerging economies such as China, India, Brazil, Russia, South Africa (BRICS) countries will also fuel the demand for these devices in future years.
- Increasing government funding for research on new technologies to treat chronic diseases will also fuel the demand for these devices.
Industry Growth Insights published a new data on “Energy based Ablation Devices Market”. The research report is titled “Energy based Ablation Devices Market research by Types (Electrical, Light, Radiation, Radiofrequency, Ultrasound, Others), By Applications (Ophthalmic Surgery, General Surgery, Cancer Therapy, Cardiovascular Disease, Others), By Players/Companies Abbott EP (USA), AngioDynamics, Inc. (USA), AtriCure, Inc. (USA), biolitec AG (Germany), Biosense Webster, Inc. (USA), Boston Scientific Corporation (USA), BTG Plc (UK), Cardiogenesis Corporation (USA), Cynosure, Inc. (USA), Conmed Corporation (USA), EDAP TMS S.A. (France), Ethicon Endo-Surgery, Inc. (USA), Halyard Health, Inc. (USA)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Energy based Ablation Devices Market Research Report
By Type
Electrical, Light, Radiation, Radiofrequency, Ultrasound, Others
By Application
Ophthalmic Surgery, General Surgery, Cancer Therapy, Cardiovascular Disease, Others
By Companies
Abbott EP (USA), AngioDynamics, Inc. (USA), AtriCure, Inc. (USA), biolitec AG (Germany), Biosense Webster, Inc. (USA), Boston Scientific Corporation (USA), BTG Plc (UK), Cardiogenesis Corporation (USA), Cynosure, Inc. (USA), Conmed Corporation (USA), EDAP TMS S.A. (France), Ethicon Endo-Surgery, Inc. (USA), Halyard Health, Inc. (USA)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Energy based Ablation Devices Market Report Segments:
The global Energy based Ablation Devices market is segmented on the basis of:
Types
Electrical, Light, Radiation, Radiofrequency, Ultrasound, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ophthalmic Surgery, General Surgery, Cancer Therapy, Cardiovascular Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott EP (USA)
- AngioDynamics, Inc. (USA)
- AtriCure, Inc. (USA)
- biolitec AG (Germany)
- Biosense Webster, Inc. (USA)
- Boston Scientific Corporation (USA)
- BTG Plc (UK)
- Cardiogenesis Corporation (USA)
- Cynosure, Inc. (USA)
- Conmed Corporation (USA)
- EDAP TMS S.A. (France)
- Ethicon Endo-Surgery, Inc. (USA)
- Halyard Health, Inc. (USA)
Highlights of The Energy based Ablation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electrical
- Light
- Radiation
- Radiofrequency
- Ultrasound
- Others
- By Application:
- Ophthalmic Surgery
- General Surgery
- Cancer Therapy
- Cardiovascular Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Energy based Ablation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Energy based ablation devices are medical devices that use heat or electricity to destroy tissue. They are used to treat a variety of conditions, including cancer.
Some of the major companies in the energy based ablation devices market are Abbott EP (USA), AngioDynamics, Inc. (USA), AtriCure, Inc. (USA), biolitec AG (Germany), Biosense Webster, Inc. (USA), Boston Scientific Corporation (USA), BTG Plc (UK), Cardiogenesis Corporation (USA), Cynosure, Inc. (USA), Conmed Corporation (USA), EDAP TMS S.A. (France), Ethicon Endo-Surgery, Inc. (USA), Halyard Health, Inc. (USA).
The energy based ablation devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Energy based Ablation Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Energy based Ablation Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Energy based Ablation Devices Market - Supply Chain
4.5. Global Energy based Ablation Devices Market Forecast
4.5.1. Energy based Ablation Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Energy based Ablation Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Energy based Ablation Devices Market Absolute $ Opportunity
5. Global Energy based Ablation Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Energy based Ablation Devices Market Size and Volume Forecast by Type
5.3.1. Electrical
5.3.2. Light
5.3.3. Radiation
5.3.4. Radiofrequency
5.3.5. Ultrasound
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Energy based Ablation Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Energy based Ablation Devices Market Size and Volume Forecast by Application
6.3.1. Ophthalmic Surgery
6.3.2. General Surgery
6.3.3. Cancer Therapy
6.3.4. Cardiovascular Disease
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Energy based Ablation Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Energy based Ablation Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Energy based Ablation Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Energy based Ablation Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Energy based Ablation Devices Demand Share Forecast, 2019-2026
9. North America Energy based Ablation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Energy based Ablation Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Energy based Ablation Devices Market Size and Volume Forecast by Application
9.4.1. Ophthalmic Surgery
9.4.2. General Surgery
9.4.3. Cancer Therapy
9.4.4. Cardiovascular Disease
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Energy based Ablation Devices Market Size and Volume Forecast by Type
9.7.1. Electrical
9.7.2. Light
9.7.3. Radiation
9.7.4. Radiofrequency
9.7.5. Ultrasound
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Energy based Ablation Devices Demand Share Forecast, 2019-2026
10. Latin America Energy based Ablation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Energy based Ablation Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Energy based Ablation Devices Market Size and Volume Forecast by Application
10.4.1. Ophthalmic Surgery
10.4.2. General Surgery
10.4.3. Cancer Therapy
10.4.4. Cardiovascular Disease
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Energy based Ablation Devices Market Size and Volume Forecast by Type
10.7.1. Electrical
10.7.2. Light
10.7.3. Radiation
10.7.4. Radiofrequency
10.7.5. Ultrasound
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Energy based Ablation Devices Demand Share Forecast, 2019-2026
11. Europe Energy based Ablation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Energy based Ablation Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Energy based Ablation Devices Market Size and Volume Forecast by Application
11.4.1. Ophthalmic Surgery
11.4.2. General Surgery
11.4.3. Cancer Therapy
11.4.4. Cardiovascular Disease
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Energy based Ablation Devices Market Size and Volume Forecast by Type
11.7.1. Electrical
11.7.2. Light
11.7.3. Radiation
11.7.4. Radiofrequency
1.7.5. Ultrasound
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Energy based Ablation Devices Demand Share, 2019-2026
12. Asia Pacific Energy based Ablation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Energy based Ablation Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Energy based Ablation Devices Market Size and Volume Forecast by Application
12.4.1. Ophthalmic Surgery
12.4.2. General Surgery
12.4.3. Cancer Therapy
12.4.4. Cardiovascular Disease
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Energy based Ablation Devices Market Size and Volume Forecast by Type
12.7.1. Electrical
12.7.2. Light
12.7.3. Radiation
12.7.4. Radiofrequency
12.7.5. Ultrasound
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Energy based Ablation Devices Demand Share, 2019-2026
13. Middle East & Africa Energy based Ablation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Energy based Ablation Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Energy based Ablation Devices Market Size and Volume Forecast by Application
13.4.1. Ophthalmic Surgery
13.4.2. General Surgery
13.4.3. Cancer Therapy
13.4.4. Cardiovascular Disease
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Energy based Ablation Devices Market Size and Volume Forecast by Type
13.7.1. Electrical
13.7.2. Light
13.7.3. Radiation
13.7.4. Radiofrequency
13.7.5. Ultrasound
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Energy based Ablation Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Energy based Ablation Devices Market: Market Share Analysis
14.2. Energy based Ablation Devices Distributors and Customers
14.3. Energy based Ablation Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott EP (USA)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AngioDynamics, Inc. (USA)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AtriCure, Inc. (USA)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. biolitec AG (Germany)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biosense Webster, Inc. (USA)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Boston Scientific Corporation (USA)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. BTG Plc (UK)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cardiogenesis Corporation (USA)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cynosure, Inc. (USA)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Conmed Corporation (USA)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. EDAP TMS S.A. (France)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Ethicon Endo-Surgery, Inc. (USA)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Halyard Health, Inc. (USA)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook